Grant Opportunities from Pfizer Inc.
Explore all the grants from the leading funding organizations of the world in a single place
Pfizer Quality Improvement Request for Proposals: Implementing Shared Decision Making in Hemophilia Patient Care
Pfizer Inc. offers grants up to $30,000 for US-based organizations to implement Shared Decision Making tools and patient-reported outcomes in hemophilia patient care.
Published At
Advancing Adult Immunization Strategies: A Focus on the Impact of Respiratory Syncytial Virus (RSV) and Cardiorespiratory Outcomes
Pfizer Inc. offers grants up to $200,000 for medical education initiatives focused on the impact of RSV infection and cardiorespiratory outcomes in high-risk adults.
Published At
Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
Pfizer Inc. offers grants up to $250,000 for educational activities to improve healthcare professional understanding of clinical data and management in ALK+ mNSCLC.
Published At
AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
Pfizer Inc. offers research grants for AI-enabled solutions to improve COVID-19 antiviral treatment access and manage drug-drug interactions for eligible patients.
Published At
Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
Pfizer Inc. offers research grants up to $100,000 for US-based investigators to evaluate the impact of early vs. delayed ritlecitinib treatment in Alopecia Areata patients.
Published At
Biochemical and Molecular Characterization of Marstacimab and TFPI Pathways
Pfizer Inc. offers research grants for basic science studies on TFPI, anti-TFPI Monoclonal Antibodies, and marstacimab to advance molecular and cellular understanding.
Published At
Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
Pfizer Inc. offers research grants for preclinical studies on TFPI modulation in non-hemophilic bleeding disorders, supporting investigators with up to $50,000 USD.
Published At
Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice
Pfizer Inc. offers grants up to $250,000 for independent medical education to improve community healthcare professional competence in managing R/R LBCL.
Published At
Independent Medical Education Grants for Post-COVID Conditions
Funding opportunity for educational initiatives aimed at improving the management of post-COVID conditions, focusing on health disparities...
Published At